Literature DB >> 24145349

BCCIP suppresses tumor initiation but is required for tumor progression.

Yi-Yuan Huang1, Li Dai, Dakim Gaines, Roberto Droz-Rosario, Huimei Lu, Jingmei Liu, Zhiyuan Shen.   

Abstract

Dysfunctions of genome caretaker genes contribute to genomic instability and tumor initiation. Because many of the caretaker genes are also essential for cell viability, permanent loss of function of these genes would prohibit further tumor progression. How essential caretaker genes contribute to tumorigenesis is not fully understood. Here, we report a "hit-and-run" mode of action for an essential caretaker gene in tumorigenesis. Using a BRCA2-interacting protein BCCIP as the platform, we found that a conditional BCCIP knockdown and concomitant p53 deletion caused rapid development of medulloblastomas, which bear a wide spectrum of alterations involving the Sonic Hedgehog (Shh) pathway, consistent with a caretaker responsibility of BCCIP on genomic integrity. Surprisingly, the progressed tumors have spontaneously lost the transgenic BCCIP knockdown cassette and restored BCCIP expression. Thus, a transient downregulation of BCCIP, but not necessarily a permanent mutation, is sufficient to initiate tumorigenesis. After the malignant transformation has been accomplished and autonomous cancer growth has been established, BCCIP reverses its role from a tumor-initiation suppressor to become a requisite for progression. This exemplifies a new type of tumor suppressor, which is distinct from the classical tumor suppressors that are often permanently abrogated during tumorigenesis. It has major implications on how a nonmutagenic or transient regulation of essential caretaker gene contributes to tumorigenesis. We further suggest that BCCIP represents a paradoxical class of modulators for tumorigenesis as a suppressor for initiation but a requisite for progression (SIRP).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24145349      PMCID: PMC3918420          DOI: 10.1158/0008-5472.CAN-13-1766

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  50 in total

1.  Phosphorylation of the PTEN tail regulates protein stability and function.

Authors:  F Vazquez; S Ramaswamy; N Nakamura; W R Sellers
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

Review 2.  Hedgehog-Gli signalling and the growth of the brain.

Authors:  Ariel Ruiz i Altaba; Verónica Palma; Nadia Dahmane
Journal:  Nat Rev Neurosci       Date:  2002-01       Impact factor: 34.870

3.  hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo.

Authors:  L Zhuo; M Theis; I Alvarez-Maya; M Brenner; K Willecke; A Messing
Journal:  Genesis       Date:  2001-10       Impact factor: 2.487

4.  Inhibition of breast and brain cancer cell growth by BCCIPalpha, an evolutionarily conserved nuclear protein that interacts with BRCA2.

Authors:  J Liu; Y Yuan; J Huan; Z Shen
Journal:  Oncogene       Date:  2001-01-18       Impact factor: 9.867

5.  Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma.

Authors:  R H Zurawel; C Allen; S Chiappa; W Cato; J Biegel; P Cogen; F de Sauvage; C Raffel
Journal:  Genes Chromosomes Cancer       Date:  2000-01       Impact factor: 5.006

6.  A molecular fingerprint for medulloblastoma.

Authors:  Youngsoo Lee; Heather L Miller; Patricia Jensen; Roberto Hernan; Michele Connelly; Cynthia Wetmore; Frederique Zindy; Martine F Roussel; Tom Curran; Richard J Gilbertson; Peter J McKinnon
Journal:  Cancer Res       Date:  2003-09-01       Impact factor: 12.701

7.  Inhibition of G1 to S cell cycle progression by BCCIP beta.

Authors:  Xiangbing Meng; Jingmei Liu; Zhiyuan Shen
Journal:  Cell Cycle       Date:  2004-03-01       Impact factor: 4.534

8.  Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors.

Authors:  Anna Marie Kenney; Michael D Cole; David H Rowitch
Journal:  Development       Date:  2003-01       Impact factor: 6.868

9.  Genomic structure of the human BCCIP gene and its expression in cancer.

Authors:  Xiangbing Meng; Jingmei Liu; Zhiyuan Shen
Journal:  Gene       Date:  2003-01-02       Impact factor: 3.688

Review 10.  The developmental biology of brain tumors.

Authors:  R Wechsler-Reya; M P Scott
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

View more
  20 in total

1.  The Transient Inactivation of the Master Cell Cycle Phosphatase Cdc14 Causes Genomic Instability in Diploid Cells of Saccharomyces cerevisiae.

Authors:  Oliver Quevedo; Cristina Ramos-Pérez; Thomas D Petes; Félix Machín
Journal:  Genetics       Date:  2015-05-12       Impact factor: 4.562

2.  p53 mediated apoptosis in osteosarcoma MG-63 cells by inhibition of FANCD2 gene expression.

Authors:  Peng Xia; Yifu Sun; Changjun Zheng; Tingting Hou; Mingyang Kang; Xiaoyu Yang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

3.  Expression pattern of BCCIP in hepatocellular carcinoma is correlated with poor prognosis and enhanced cell proliferation.

Authors:  Zhipeng Lin; Baoying Hu; Wenkai Ni; Xiaofei Mao; Huiling Zhou; Jiale Lv; Bihui Yin; Zhongyi Shen; Miaomiao Wu; Wensen Ding; Mingbing Xiao; Runzhou Ni
Journal:  Tumour Biol       Date:  2016-11-10

4.  High Expression of BCCIP β Can Promote Proliferation of Esophageal Squamous Cell Carcinoma.

Authors:  Lingling Chen; Sujie Ni; Mei Li; Chaoyan Shen; Zhipeng Lin; Yu Ouyang; Fei Xia; Li Liang; Wenyan Jiang; Runzhou Ni; Jianguo Zhang
Journal:  Dig Dis Sci       Date:  2016-12-19       Impact factor: 3.199

5.  Spontaneous Development of Hepatocellular Carcinoma and B-Cell Lymphoma in Mosaic and Heterozygous Brca2 and Cdkn1a Interacting Protein Knockout Mice.

Authors:  Huimei Lu; Caiyong Ye; Xing Feng; Jingmei Liu; Mantu Bhaumik; Bing Xia; Chen Liu; Zhiyuan Shen
Journal:  Am J Pathol       Date:  2020-03-20       Impact factor: 4.307

6.  Loss of Setd4 delays radiation-induced thymic lymphoma in mice.

Authors:  Xing Feng; Huimei Lu; Jingyin Yue; Neta Schneider; Jingmei Liu; Lisa K Denzin; Chang S Chan; Subhajyoti De; Zhiyuan Shen
Journal:  DNA Repair (Amst)       Date:  2019-11-25

7.  The flow cytometry-defined light chain cytoplasmic immunoglobulin index and an associated 12-gene expression signature are independent prognostic factors in multiple myeloma.

Authors:  X Papanikolaou; D Alapat; A Rosenthal; C Stein; J Epstein; R Owens; S Yaccoby; S Johnson; C Bailey; C Heuck; E Tian; A Joiner; F van Rhee; R Khan; M Zangari; Y Jethava; S Waheed; F Davies; G Morgan; B Barlogie
Journal:  Leukemia       Date:  2015-03-10       Impact factor: 11.528

8.  FH535 inhibited metastasis and growth of pancreatic cancer cells.

Authors:  Meng-Yao Wu; Rong-Rui Liang; Kai Chen; Meng Shen; Ya-Li Tian; Dao-Ming Li; Wei-Ming Duan; Qi Gui; Fei-Ran Gong; Lian Lian; Wei Li; Min Tao
Journal:  Onco Targets Ther       Date:  2015-07-06       Impact factor: 4.147

9.  Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup.

Authors:  Evelina Miele; Angela Mastronuzzi; Agnese Po; Andrea Carai; Vincenzo Alfano; Annalisa Serra; Giovanna Stefania Colafati; Luisa Strocchio; Manila Antonelli; Francesca Romana Buttarelli; Massimo Zani; Sergio Ferraro; Amelia Buffone; Alessandra Vacca; Isabella Screpanti; Felice Giangaspero; Giuseppe Giannini; Franco Locatelli; Elisabetta Ferretti
Journal:  Biomark Res       Date:  2015-06-06

10.  The p53 tumor suppressor protein protects against chemotherapeutic stress and apoptosis in human medulloblastoma cells.

Authors:  Sarah Waye; Aisha Naeem; Muhammad Umer Choudhry; Erika Parasido; Lucas Tricoli; Angiela Sivakumar; John P Mikhaiel; Venkata Yenugonda; Olga C Rodriguez; Sana D Karam; Brian R Rood; Maria Laura Avantaggiati; Chris Albanese
Journal:  Aging (Albany NY)       Date:  2015-10       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.